Company Data
Outlook Therapeutics Inc.
Ticker
OTLK
Current Price
$1.78 4.09%
Market Cap
$59.8M
Price Target
Refer to Report
Volume
595.8K
52wk Range
$0.87 - $9.25
Overview
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.